Condition
Alcohol Effect
Total Trials
5
Recruiting
0
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
P 1 (5)
Trial Status
Active Not Recruiting4
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02710097Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02709954Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02404688Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02710331Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
NCT01590277Phase 1Completed
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Showing all 5 trials